<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02750787</url>
  </required_header>
  <id_info>
    <org_study_id>DA12</org_study_id>
    <nct_id>NCT02750787</nct_id>
  </id_info>
  <brief_title>Use of a Peptide-based Formula in an Adult Population</brief_title>
  <official_title>An Evaluation of the Use of a Peptide-based Formula in an Adult Population</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Abbott Nutrition</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Abbott Nutrition</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study is designed to observe the use of a peptide-based oral nutrition supplement in
      adults with chronic malabsorption or maldigestion who require supplemental nutrition as
      assessed by a clinician.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">August 2016</start_date>
  <completion_date type="Actual">July 2017</completion_date>
  <primary_completion_date type="Actual">July 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Study Product Consumption</measure>
    <time_frame>Day 1 to Day 23</time_frame>
    <description>Subject Diary</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Body Mass Index</measure>
    <time_frame>Change from Screening to Day 23</time_frame>
    <description>Calculated from Height and Weight</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Medication Use</measure>
    <time_frame>Screening to Study Day 23</time_frame>
    <description>Subject Interview of Dose, Unit and Frequency</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse Events</measure>
    <time_frame>Screening to Day 25</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">37</enrollment>
  <condition>Malabsorption</condition>
  <arm_group>
    <arm_group_label>Nutritional Study Product</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>A ready-to-drink peptide-based liquid formula for patients with impaired gastro-intestinal function.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Nutritional Study Product</intervention_name>
    <description>Two 220 ml servings per day</description>
    <arm_group_label>Nutritional Study Product</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subject is â‰¥ 18 years of age.

          -  Subject has chronic malabsorption or maldigestion.

          -  Subject requires supplemental nutrition as assessed by a clinician.

          -  Subject agrees to consume 2 servings of the study product a day for at least 16
             consecutive days during Treatment period.

        Exclusion Criteria:

          -  Subject is currently taking or has taken antibiotics within 2 weeks prior to
             enrollment in the study.

          -  Subject has current active malignant disease or was treated within the last 6 months
             for cancer.

          -  Subject has a history of diabetes mellitus.

          -  Subject is pregnant as demonstrated by a urine pregnancy test.

          -  Subject has severe auto immune disease and is on immuno-modulating therapy.

          -  Subject has a history of allergy to any of the ingredients in the study product.

          -  Subject has active HIV.

          -  Subject has a known aversion to flavor of product being tested.

          -  Subject has known dementia, brain metastases, eating disorders, history of significant
             neurological or psychiatric disorder, or any other psychological condition that may
             interfere with study product consumption.

          -  Subject has an obstruction of the gastrointestinal tract precluding ingestion or
             absorption of the study product.

          -  Subject is taking part in another non-Sponsor approved clinical trial.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jeffrey L Nelson, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Abbott Nutrition</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>St. Boniface Hospital</name>
      <address>
        <city>Winnipeg</city>
        <state>Manitoba</state>
        <zip>R2H 2A6</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>July 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 19, 2016</study_first_submitted>
  <study_first_submitted_qc>April 21, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 26, 2016</study_first_posted>
  <last_update_submitted>July 21, 2017</last_update_submitted>
  <last_update_submitted_qc>July 21, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">July 24, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Malabsorption Syndromes</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

